Jameel Investment Management Company

What Jameel Investment Management Company does

Jameel Investment Management Company (JIMCO) is the global investment arm of the Abdul Latif Jameel family and operates as a privately held, single-family office headquartered in St. Helier, Jersey, Channel Islands. Founded in 2011 and backed by a family enterprise with roots dating to 1945, JIMCO manages more than US$2.5 billion in committed capital across three primary vehicles: a Life Sciences Fund launched in 2020, an evergreen Technology Fund initially seeded at US$500 million, and a Strategic Asset Fund established in 2018. The firm employs 251-500 people across 14 offices globally and operates without external limited partners, deriving all capital from family balance-sheet sources.

JIMCO's investment activity is concentrated in frontier technology, life sciences, mobility, fintech, and energy transition. Notable disclosed positions include Rivian in electric vehicles, Joby Aviation in eVTOL, Commonwealth Fusion Systems and General Fusion in commercial fusion, EQRx, Cambridge Epigenetix, Cellarity, and Revolution Medicines in life sciences, Tabby, Rain, Lean, Ziina, and Figopara in fintech, Starship Technologies in autonomous delivery, and Ever in AI-native auto retail. The firm maintains formal academic research partnerships with MIT, Imperial College London, and the University of Tokyo to source frontier-science deal flow.

The business model is that of a patient, multi-generational capital allocator rather than a conventional asset manager. Because all funds are family-sourced, JIMCO does not earn external management fees or carried interest from third-party LPs. Returns are generated entirely through direct equity ownership, co-investment economics, and long-duration appreciation of portfolio holdings. The evergreen structure of the Technology Fund and the multi-strategy buildout (life sciences, technology, strategic assets) indicate a deliberate shift from opportunistic investing toward institutionalized, thesis-driven capital deployment across the family office.

Name

Jameel Investment Management Company

Legal name

Abdul Latif Jameel Investment Management Company Holding II Limited

Website

https://jimco.com/

Company type

Private

Founded year

1945

Operating status

Operating

Headcount range

251–500 employees

Short description

Jameel Investment Management Company (JIMCO) is the single-family investment arm of the Abdul Latif Jameel family, managing US$2.5bn+ across Life Sciences, Technology, and Strategic Asset funds. It invests patient capital in frontier tech, biotech, mobility, fintech, and energy transition from 14 global offices.

Ownership category

akta.pro rank

Product category

Private Equity & Venture Capital Investment Management

NAICS

All Other Financial Investment Activities (52399), Portfolio Management and Investment Advice (52394)

SIC

Investment Advice (6282), Investors, Nec (6799)

akta.pro primary industry

Corporate Strategic Partnership & Ecosystem Investment Arms (FSANAHAF)

akta.pro secondary industries

Captive CVC Fund (Dedicated corporate fund structure) (FSANAHAB), Corporate LP Programs (Corporate as LP in VC/PE funds) (FSANAHAH)

Keywords

• Venture capital investing
• Private equity funds
• Life sciences investment
• Family office management
• Sustainable investment funds

Headquarters

HQ city

St. Helier

Offices14 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure, Others

Revenue model

1. Investment Returns: JIMCO generates returns through capital appreciation and exit proceeds from their investment portfolio of early-stage ventures and funds. Returns are realized through IPOs, acquisitions, and secondary transactions.
2. Fund Management: The Technology Fund was initially a US$500 million fund with one limited partnership, structured as an 'evergreen' fund enabling rapid access to additional capital for outstanding investment opportunities.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Core offering

JIMCO is a private family investment office that makes direct venture and growth investments and commits capital to third-party venture and private equity funds. It manages three dedicated funds—the Life Sciences Fund, Technology Fund, and Strategic Asset Fund—deploying US$2.5 billion+ of committed capital into early-stage technology ventures, healthcare/life sciences companies, and sustainable/ESG-aligned assets. Its offering combines capital with operational mentorship, regional market expertise, and access to the Jameel Family's global commercial network across 30+ markets.

Product overview

Jameel Investment Management Company (JIMCO) is a global investment firm managing three specialized investment funds: the Life Sciences Fund, Technology Fund, and Strategic Asset Fund. The Life Sciences Fund focuses on healthcare innovation including digital health and precision medicine. The Technology Fund invests in fintech, future mobility, and emergent technologies. The Strategic Asset Fund supports sustainable energy and infrastructure investments. JIMCO also maintains a direct investment portfolio in portfolio companies across electric vehicles, air mobility, fintech, fusion energy, and life sciences.

Differentiator

Problem solved

Functional benefit

Brands

• JIMCO Life Sciences Fund: Investment fund focused on advancing access to modern medical care, investing in digital health, AI, precision medicine, advanced medical devices, diagnostics, genomics, and regenerative medicine.
• JIMCO Technology Fund
• JIMCO Strategic Asset Fund

Products and services

• JIMCO Life Sciences Fund Venture capital fund focused on accelerating access to modern medical care by investing in digital health, AI, precision medicine, advanced medical devices, diagnostics, genomics, regenerative medicine, and animal health. Targeted at founders and management teams of breakthrough life sciences companies.
• JIMCO Technology Fund Investment fund dedicated to advancing emergent technologies across fintech, insurtech, energy, water, renewables, AI, software, cloud computing, consumer platforms, agritech, and future mobility solutions. Initially capitalized at US$500 million+ and structured as an evergreen vehicle for rapid capital deployment. Targeted at founders and executives of fast-growing, technology-driven startups.
• JIMCO Strategic Asset Fund Investment fund backing fund managers focused on sustainable approaches for food and water production, energy transformation, decarbonization, renewables, distributed energy, electrification, and water infrastructure. Targeted at sustainable/ESG-aligned fund managers and institutional investors.
• JIMCO Portfolio Companies (Direct Investment Program) Direct equity investments in individual portfolio companies across technology and life sciences, including electric vehicles (Rivian), air mobility (Joby Aviation), fintech (Tabby, Rain, Lean Technologies), fusion energy (General Fusion, Commonwealth Fusion Systems), and healthcare (Revolution Medicines, Cambridge Epigenetix, Cellarity, EQRx). Targeted at founders and management teams of breakthrough technology and life sciences companies.

Quantifiable outcome

• Portfolio company Rivian IPO raised almost US$12 billion for a valuation of US$66.5 billion
• +4 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Three partnerships are on record, tiered core and minor.

• Massachusetts Institute of Technology (MIT)coreStrategic or Co-development PartnerJIMCO maintains strong relationships with MIT, including the Jameel Clinic at MIT and MIT Plasma Science & Fusion Center where Commonwealth Fusion Systems originated. CFS is an MIT spinout from this research center.
• Imperial College LondoncoreStrategic or Co-development PartnerJIMCO maintains relationship with Imperial College London through the Jameel Institute, continuing the Jameel Family's commitment to breakthrough science and healthcare innovation.
• University of TokyominorStrategic or Co-development PartnerJIMCO has relationships with University of Tokyo and other leading research institutions for access to research and investment opportunities.

Scale indicators16 records

Recent moves8 records

Expansion highlights5 records

Market position

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/JameelInvestmentManagement

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments28 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Jameel Investment Management Company